3,4,5,3',4'-pentachlorobiphenyl has been researched along with Porphyria Cutanea Tarda in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestra, D; Gorman, N; Jacobs, JM; Jacobs, NJ; Sinclair, JF; Sinclair, PR; Szakacs, JG; Trask, HS; Zaharia, A | 1 |
| Bement, WJ; Dalton, TP; Eisenstein, RS; Gerhard, GS; Gorman, N; Nebert, DW; Ross, KL; Sinclair, JF; Sinclair, PR; Szakacs, JG; Walton, HS | 1 |
2 other study(ies) available for 3,4,5,3',4'-pentachlorobiphenyl and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda.
Topics: Aminolevulinic Acid; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Cytochrome P-450 CYP1A2; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Iron; Iron-Dextran Complex; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Polychlorinated Biphenyls; Porphyria Cutanea Tarda; Uroporphyrins | 2007 |
Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron.
Topics: Aminolevulinic Acid; Animals; Cytochrome P-450 CYP1A2; Differential Threshold; Disease Models, Animal; Hepatocytes; Iron; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Polychlorinated Biphenyls; Porphyria Cutanea Tarda; Tissue Distribution; Uroporphyrinogen Decarboxylase; Uroporphyrins | 2002 |